Podcasts about Biologic

Facing challenges presented by psoriasis can be an emotional roller coaster. From diagnosis, treatment choices, and the impact of bullying when a child has psoriasis can leave a parent feeling alone and helpless. Finding someone who's been on the same journey can be a benefit.  Hear how parents Jessie Houston, Nadya Helt, and Emma Rhodes with moderator Michel Tarabocchia found the help and hope they needed through the NPF One to One Program. 

Send us a textThis week on The Less Stressed Life Podcast, we're diving into the world of holistic and airway dentistry with Dr. Julia Sadove-Lopez—a biological dentist turned virtual consultant who's helping families decode the wild world of oral development, mouth breathing, and pediatric dental treatment options.After moving from Chicago to Portugal (yes, really!), Dr. Julia shifted from traditional dentistry to guiding parents through finding the right solutions for their kids' sleep, airway, and oral health challenges. From picky eating to tongue ties, teeth grinding, and sleep apnea—this episode uncovers what might really be going on under the surface.In this episode, Dr. Julia shares what most parents (and adults!) don't realize about early signs of dysfunction—and what to do when the advice you're getting from different providers feels totally conflicting. We also break down her signature “three-stage” approach to airway-focused care and why you always have options.KEY TAKEAWAYS:Why “you should save for braces” might be a red flag

După succesul cu primul său volum de proză scurtă, „A râs și tata”, Remus Boldea revine în librării cu o nouă colecție de povestiri. „Degeaba ai citit atâtea cărți” se numește și a apărut la Editura Trei. Relația cu tatăl și prietenia sînt două dintre temele centrale ale volumului. Majoritatea textelor sînt scrise la persoana întîi din perspectiva unui narator tînăr sau foarte tînăr. Remus Boldea știe să scrie simplu, știe să-și construiască personajele din doar cîteva replici și, prin replicile și gesturile lor, ne dă acces la o întreagă lume: cea a micului oraș de provincie, cu tensiunile, cruzimile, tristețile și lipsa ei de perspectivă. Am stat de vorbă cu Remus Boldea despre universul din noul său volum de povestiri, despre personajele și temele sale.De ce e importantă pentru tine relația tată-fiu?Remus Boldea: „Îmi aduc aminte de ceva ce a zis Mircea Cărtărescu: tot ce scriem noi ca scriitori și scriitoare sînt un fel de scrisori adresate tatălui. N-am înțeles ce-a vrut să zică atunci cînd am citit prima dată asta într-un interviu, dar acum, scriind două cărți unde tatăl este personajul central, încep să înțeleg. Relația cu tatăl este problematică pentru că tatăl e mult mai predispus să te părăsească decît mama. Biologic vorbind, tatăl nu-i atît de legat de copii. El cumva alege să rămînă în familie - la un nivel macro, nu zic că toți tații fac așa, vorbesc de ceva simbolic. Eu chiar am trăit un episod profund. Cînd aveam 5 ani, tatăl meu a suferit de depresie și cîțiva ani nu a fost deloc prezent, pentru că a fost internat în tot felul de locuri. Și chiar și atunci cînd s-a întors, era prezent mai mult fizic și atît. Dar asta nu avea legătură neapărat cu depresia cît cu faptul că așa erau tații din Motru. Vorbeam cu colegi de-ai mei de clasă și cam ăsta era patternul. Tații doar erau acolo, să fie, se uitau la televizor... Prea puțini au avut o relație apropiată cu tații lor. Dar am început să mă apropii foarte tare de el și de mama mea cam pe la 25 de ani, a fost ca un fel de renaștere a relației. Am putut să mă uit fără prea multă durere la lucrurile acelea și am vrut să le recuperez și să le împărtășesc. Pentru mine au fost experiențe valoroase și poate cineva se regăsește în ele sau își amintește de propria relație cu tatăl și asta e important.” Ce ai lăsat să treacă din poveștile tale de viață în povestiri? Remus Boldea: „Am o naivitate copilărească, nu-mi vine să cred că lucrurile sînt așa cum sînt, că relațiile între oameni sînt așa și nu altfel. Orice fel de artist trebuie să aibă atitudinea asta a copilului: să nu accepte răspunsuri gata făcute.”Apasă PLAY pentru a asculta interviul integral!O emisiune de Adela Greceanu  Un produs Radio România Cultural  

In this episode of Six to Eight Weeks, Dr. Drew Lansdown and Dr. Brian Feeley break down what's new in rotator cuff repair surgery. From surgical technique to regenerative medicine, tendon transfers to reverse shoulder replacements, this is a comprehensive look at what we know, what we've learned, and where the field is going

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTR865. CME/MOC/AAPA credit will be available until March 10, 2026.Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

 Show notes  To learn more about the 10th anniversary of the first FDA biosimilar approval, click here.  To learn more about how much biosimilars have saved so far, click here.  To read more about Josh's views on the pharmaceutical landscape in 2025, click here. 

Summary In this episode of the Future of Dermatology Podcast, we hear from Dr. Maria Aleshin who spoke at the Annual SF Derm Society's 2024 Meeting. She presents on Hidradenitis Suppurativa (HS) and various non-biologic treatment strategies. Dr. Aleshin covers practical approaches to managing HS flare-ups, long-term management considerations, and the role of antibiotics in treatment. She emphasizes the importance of personalized care and the need for a multifaceted approach to effectively address this challenging skin condition.   Takeaways The pathogenesis of HS is multifactorial, requiring a comprehensive treatment approach. Treatment stacking often involves combining medical, procedural, and lifestyle interventions. Topical therapies like chlorhexidine and benzoyl peroxide are commonly recommended, but alternatives exist. Systemic antibiotics are frequently used for managing HS flares. Hormonal therapies, including oral contraceptives and spironolactone, can be effective for female patients with HS. Metformin may be beneficial for patients with metabolic dysfunction associated with HS. Isotretinoin is not a first-line treatment for HS due to mixed results. Botulinum toxin can help reduce sweating and inflammation in HS patients. Combination antibiotic therapy, particularly clindamycin and rifampin, shows high efficacy but has relapse risks. Urtipenem is a powerful antibiotic reserved for severe HS cases as a bridge to surgery or biologics. Chapters 00:00 - Introduction to the Future of Dermatology Podcast 01:19 - Understanding Hidradenitis Suppurativa (HS) and Its Complexities 07:10 - Treatment Strategies for Managing HS Flare-Ups 10:21 - Long-Term Management of HS: Hormonal and Metabolic Considerations 13:20 - Antibiotic Therapies for Hidradenitis Suppurativa 17:22 - Severe HS Cases: Advanced Treatment Options and Considerations

About the Guest Scott Dee earned a DVM, MS, and PhD from the University of Minnesota, is board-certified in veterinary microbiology, past President of the American Association of Swine Veterinarians, past Chair of the American Veterinary Medical Association (AVMA) Council on Biologic and Therapeutic Agents and currently serves on the AVMA House of Delegates. After […]

Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation. Research discussedClinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumabFactors Associated with Remission of Eczema in ChildrenPersistence of Mild to Moderate Atopic Dermatitis Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NMD865. CME/MOC/CC/AAPA/IPCE credit will be available until February 17, 2026.Mastering the Art and Science of Biologic Therapy for CRSwNP: Who Are the Candidates and How Do You Manage Their Care? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NMD865. CME/MOC/CC/AAPA/IPCE credit will be available until February 17, 2026.Mastering the Art and Science of Biologic Therapy for CRSwNP: Who Are the Candidates and How Do You Manage Their Care? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NMD865. CME/MOC/CC/AAPA/IPCE credit will be available until February 17, 2026.Mastering the Art and Science of Biologic Therapy for CRSwNP: Who Are the Candidates and How Do You Manage Their Care? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Inverse psoriasis is more challenging to treat and to keep under control. Learn more as we uncover inverse psoriasis from what it is, typical symptoms and sites, other potential diseases, to being a risk factor for psoriatic arthritis, and what treatments are used either alone or in combination with dermatologist Dr. Jeffrey Cohen, Director, Psoriasis Treatment Program at Yale University School of Medicine and moderator Kaitlin Walden, RN. 

Discover the transformative world of biologic dentistry with Dr. Sonia Chopra, a board-certified endodontist whose personal journey from misdiagnosis to advocacy provides a powerful perspective on holistic dental care. We unravel the prevalent misconceptions surrounding root canals, emphasizing their role as a viable option for tooth pain management while stressing the importance of preserving natural teeth. This episode illuminates the significance of accurate diagnosis and informed consent, providing clarity for patients seeking to make informed decisions that align with their personal health values.Explore the cutting-edge advancements revolutionizing root canal treatments today. With Dr. Chopra's expertise, we dive into the technologies reshaping the field, such as the GentleWave system and laser therapy, which enhance treatment precision and efficacy. These tools, combined with innovative imaging techniques, help address even the most complex cases, leading to faster healing and improved patient outcomes. We highlight the necessity of understanding each "tooth story" and selecting providers who are equipped with the latest technological capabilities to transform your dental experience.We conclude with a deeper look into biological endodontics and the broader health implications of proper root canal diagnosis. Dr. Chopra shares real-life case studies that underscore the body's incredible resilience and healing capacity. By integrating advanced techniques and natural remedies, we aim to align dental practices with the body's natural healing processes. This episode encourages both patients and professionals to continuously seek knowledge and stay informed about the latest developments in endodontics, emphasizing a thoughtful and comprehensive approach to dental care. Join us for an enlightening conversation that promises to shift your perspective on root canal therapy.Check out Dr. Chopra's website here: https://drsoniachopra.com/Follow her on Instagram: https://www.instagram.com/drsoniachopra/Check out her course: https://drsoniachopra.com/endodontic-patient-course/To learn more about holistic dentistry, check out Dr. Carver's website:http://carverfamilydentistry.comTo contact Dr. Carver directly, email her at drcarver@carverfamilydentistry.comWant to talk with someone at Dr. Carver's office?  Call her practice: 413-663-7372Reverse Gum Disease In 6 Weeks! With Dr. Rachaele Carver Online Course!Learn more about here: https://reversegumdiseaseinsixweeks.info/optinpageDisclaimer: This podcast is for educational purposes only. Information discussed is not intended for diagnosis, curing, or prevention of any disease and is not intended to replace advice given by a licensed healthcare practitioner. Before using any products mentioned or attempting methods discussed, please speak with a licensed healthcare provider. This podcast disclaims responsibility from any possible adverse reactions associated with products or methods discussed. Opinions from guests are their own, and this podcast does not condone or endorse opinions made by guests. We do not provide guarantees about the guests' qualifications or credibility. This podcast and its guests may have direct or indirect financial interests associated with products mentioned.

Did you know that you can actually regrow your teeth without invasive dental surgeries, fillings or toxic materials? Well if you didn't now you do - and we're talking about it in this epsiode with the world famous biologic dentist: Dr. Gerry Curatola.   TOPICS DISCUSSED IN THIS EPISODE: How your teeth can regrow and regenerate and heal cavities The mouth-gut-whole bod disease connection The role of saliva in remineralizing your teeth and healing your microbiome Different therapies to regrow your teeth naturally The toxicity of modern dentistry 5 important levels of healing to prevent disease in your own body   More from The Parsons Gerry's Instagram: @drgerrycuratola Clinic Instagram: @rejuvenationhealth Website: rejuv-health.com   Leave us a Review: https://www.reversablepod.com/review   Need help with your gut? Visit my website gutsolution.ca to join a program: Get help now   Contact us: reversablepod.com/tips    SOCIAL MEDIA: Instagram  Facebook  YouTube        

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this special episode of The Drive, Peter introduces a brand-new roundtable format. Joined by three renowned experts in longevity science—Steven Austad, Richard Miller, and Matt Kaeberlein—the group explores the rapidly evolving field of geroscience. Together, they dive deep into topics like the relationship between healthspan and lifespan, evaluating interventions like rapamycin and senolytics, the role of epigenetic changes in aging, and whether GLP-1 receptor agonists hold geroprotective potential. They also tackle major challenges in funding and public acceptance of longevity research including how geroprotective interventions might be tested in humans. Packed with nuanced debate, humor, and groundbreaking insights, this episode is a must-listen for anyone fascinated by the science of aging. We discuss: The recent rise in public interest in longevity, misconceptions, and the link between healthspan and lifespan [3:45]; Redefining healthspan, the US healthcare paradox, and separating longevity science from commercial hype [12:30]; The need to redirect medical research from disease-specific models to aging-focused approaches [21:30]; Proactive healthcare: rethinking health, disease, and the role of aging [30:00]; Biologic age versus chronologic age, and the limitations and potential of epigenetic clocks [35:00]; The utility and drawbacks of the “hallmarks of aging” as a framework for research and funding [49:30]; The role of epigenetic changes in aging and the challenges of proving causality [56:45]; The translational challenges of moving aging research from preclinical studies to human applications [1:03:45]; Distinguishing between a biomarker of aging and aging rate indicators [1:17:15]; The difficulties of translating longevity research in mice to humans, and the difficulties of testing interventions in humans [1:21:15]; Exercise, aging, and healthspan: does exercise slow aging? [1:35:45]; Are GLP-1 receptor agonists geroprotective beyond caloric restriction effects? [1:41:00]; The role of senescent cells in aging, challenges with reproducibility in studies, and differing views on the value of current research approaches [1:46:15]; How funding challenges and leadership in NIH and other institutes impact the advancement of aging-related research [2:00:15]; Metformin: geroprotective potential, mechanisms, and unanswered questions [2:02:30]; Canagliflozin and rapamycin as geroprotective molecules: mechanisms, dosing strategies, and longevity potential [2:10:45]; Resveratrol and NAD precursors—a lack of evidence for anti-aging effects [2:22:45]; The potential of parabiosis and plasmapheresis to slow aging, the challenges in translating mouse studies to humans, and possible design for human studies [2:29:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Can artificial intelligence redefine the future of drug development and clinical trials?  In this episode of Tech Talks Daily, I sit down with Dave Latshaw, Ph.D., the internationally recognized AI and machine learning expert who serves as CEO of BioPhy. Founded in 2019, BioPhy focuses on using AI to revolutionize the later stages of drug development, a critical yet often overlooked segment of the pharmaceutical pipeline. Dave shares insights into BioPhy's innovative platform, which combines scientific, clinical, and regulatory insights to predict clinical trial success and steer capital allocation. At the heart of BioPhy's approach is its patent-pending AI engine, BioLogic, and generative AI solution, BioPhyRx, designed to enhance clinical trial outcomes, reduce failure rates, and accelerate the time to market for life-saving drugs. Dave also explores how BioPhy's operational assessment model prioritizes immediate ROI by addressing challenges downstream from drug discovery. In our conversation, Dave delves into the complexities of AI adoption in pharma, including the challenges of scaling AI solutions, managing high computational costs, and overcoming stakeholder fears about job displacement. Drawing from his experience at Johnson & Johnson, where his AI innovations contributed to the global rollout of the COVID-19 vaccine, Dave reflects on lessons learned and the transformative potential of AI in healthcare. As we look ahead, Dave discusses the future of AI in reducing administrative burdens on clinicians, automating regulatory compliance, and enabling groundbreaking advancements like DeepMind's AlphaFold.  How can AI transform not just how we develop drugs but also the healthcare outcomes for millions of people worldwide? Tune in to find out, and share your thoughts on the role of AI in the future of medicine.

We welcome Meredith Brown-Tuttle to AI Uncovered.  Meredith is the Chief Regulatory Strategist at Regulatorium, where she applies her 33 years of experience in the pharmaceutical and biologics industry. She specializes in working with small and medium-sized drug, biologic and combination product companies to navigate global regulatory strategy, intelligence and submission requirements. With a strong focus on innovation, Meredith is dedicated to revolutionizing regulatory science by integrating AI and in silico modeling into every stage of drug development. Most recently, Meredith has focused on advancing global regulatory science through the development of AI tools, aiming to streamline submission processes and improve outcomes for the industry. Her vision includes a future where entirely digital INDs, BLAs and NDAs become standard practice, supported by the widespread use of in silico modeling, digital twins and federated data sharing to enable collaboration without compromising proprietary information.In this episode, Tim  and Meredith explore the evolving landscape of global regulatory strategy and how AI can revolutionize regulatory science. Meredith shares insights from her extensive career, including her experience in crafting INDs and NDAs, her thoughts on transforming data validation standards across the industry and providing strategic guidance to companies navigating complex regulatory requirements. She also delves into the challenges and opportunities presented by AI. In addition to her work at Regulatorium, Meredith serves as a board member at the Alliance for Artificial Intelligence in Healthcare (AAIH), showcasing her commitment to leveraging innovation in regulatory affairs. Meredith is also an accomplished author of over 70 articles and two books, and she has trained thousands of professionals on writing INDs and conducting effective regulatory submissions. Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

Please visit answersincme.com/KSU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in otolaryngology discuss the role of biologic therapies in chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Recognize considerations for initiating treatment with a biologic therapy in patients with CRSwNP; Review the clinical implications of the latest efficacy and safety data for novel approved biologics in CRSwNP; and Outline strategies to optimize the use of biologics in patients with CRSwNP over the long term.

Please visit answersincme.com/KSU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in otolaryngology discuss the role of biologic therapies in chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Recognize considerations for initiating treatment with a biologic therapy in patients with CRSwNP; Review the clinical implications of the latest efficacy and safety data for novel approved biologics in CRSwNP; and Outline strategies to optimize the use of biologics in patients with CRSwNP over the long term.

Please visit answersincme.com/YWD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in rhinology discusses the use of biologics for the management of chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Identify key considerations for initiating a biologic therapy in patients with CRSwNP; Discuss the clinical impact of the latest data for novel approved biologics in CRSwNP; and Apply best practice approaches for management of biologics in patients with CRSwNP. This activity is intended for US healthcare professionals only.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Interview with Ryan Howard, MD, MS, and Dana Telem, MD, MPH, authors of Use of Biologic and Biosynthetic Mesh for Ventral Hernia Repair in Current Practice. Hosted by Amalia Cochran, MD. Related Content: Use of Biologic and Biosynthetic Mesh for Ventral Hernia Repair in Current Practice

Interview with Ryan Howard, MD, MS, and Dana Telem, MD, MPH, authors of Use of Biologic and Biosynthetic Mesh for Ventral Hernia Repair in Current Practice. Hosted by Amalia Cochran, MD. Related Content: Use of Biologic and Biosynthetic Mesh for Ventral Hernia Repair in Current Practice

Please visit answersincme.com/YZW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses biologic therapy for prurigo nodularis, and a patient presents her perspective. Upon completion of this activity, participants should be better able to: Identify the therapeutic needs of patients with PN; Review the evidence for current and emerging biologic treatments for PN; and Outline how to integrate biologic therapies into the care of patients with PN.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/DEA865. CME/MOC/AAPA credit will be available until December 7, 2025.Optimizing Outcomes for Pediatric Patients With EoE: The Importance of Timely Integration of Targeted Biologic Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/DEA865. CME/MOC/AAPA credit will be available until December 7, 2025.Optimizing Outcomes for Pediatric Patients With EoE: The Importance of Timely Integration of Targeted Biologic Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Please visit answersincme.com/YZW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses biologic therapy for prurigo nodularis, and a patient presents her perspective. Upon completion of this activity, participants should be better able to: Identify the therapeutic needs of patients with PN; Review the evidence for current and emerging biologic treatments for PN; and Outline how to integrate biologic therapies into the care of patients with PN.

Join moderator Emily Wallack as we hear how Mark, a patient living with moderate-to-severe plaque psoriasis, rediscovered self-love after finding ILUMYA® (tildrakizumab-asmn), a treatment that he receives for little to no cost with coverage under Medicare Part B with a supplement. Dermatologist Dr. Omar Noor also joins to offer insights on diagnosing and treating psoriasis. This episode is sponsored by Sun Pharma. To view important safety information: ilumya.com   

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC information, and to apply for credit, please visit us at PeerView.com/AYT865. CME/MOC/CC credit will be available until November 9, 2025.Uncovering the Role of Epithelial Cytokines in CRSwNP: Examining the Clinical Implications of New Approaches with Targeted Biologic Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca LP.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BAU865. CME/MOC/AAPA credit will be available until November 5, 2025.Breaking New Ground in the Treatment of COPD: Exploring the Potential Use of Targeted Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BAU865. CME/MOC/AAPA credit will be available until November 5, 2025.Breaking New Ground in the Treatment of COPD: Exploring the Potential Use of Targeted Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Dupilimab received FDA approval as the first biologic treatment for adults with uncontrolled COPD, reducing exacerbations significantly in clinical trials. A study in JAMA Internal Medicine demonstrated that improper arm positioning during blood pressure measurements can lead to overestimated readings, potentially causing misdiagnosis. Another study in Atherosclerosis, Thrombosis, and Vascular Biology linked COVID-19 to long-term risks of major adverse cardiac events (MACE), with increased risks for patients hospitalized with COVID-19 and those with non-O blood types. These findings underscore the need for attention to proper clinical practices and long-term monitoring of cardiovascular health post-COVID-19.

Are you curious about how biologic medications are transforming the treatment of asthma, eczema, allergies, and more? Dr. Perdita Permaul joins Dr. Gupta and Kortney to discuss the available biologic medications for allergic conditions. We walk through the eight biologics currently available for allergic diseases, explaining how these medications target different parts of the immune system to treat allergic conditions more effectively than traditional medications. Dr. Permaul explains how biologics have evolved since 2003 and how they are changing the way allergic conditions are treated. She also explains why some of the biologics treat multiple diseases, whereas some are only approved for one.  What we cover in our episode about the available biologics for allergic conditions How biologics work for allergic conditions: We unpack how biologic medications target specific parts of the immune system, reducing inflammation and improving the quality of life for patients with allergic diseases. History and evolution of biologics: Dr. Permaul walks us through the timeline of biologics, starting with Xolair in 2003 and how these treatments have expanded to target other conditions over time. Which biologics treat which conditions: From asthma and eczema to food allergies and nasal polyps, we break down which biologics are available and how they help patients with allergic conditions. Future of biologics: Dr. Permaul discusses the potential of biologics to be used for more conditions in the future, including ongoing research into food allergy treatments. Biologics Cheat Sheet Below is a list of the 8 biologics discussed in this episode. We have briefly outlined their mechanism of action along with the approved conditions and ages the drug is available for presecription.  Omalizumab (Xolair) Xolair works by binding to IgE to prevent allergic reactions. It has since been approved for chronic hives, nasal polyps, and food allergies. Allergic asthma: 6+ Chronic idiopathic urticaria (hives: 12+ Chronic rhinosinusitis with nasal polyps (CRSwNP): 18+ Food allergies:1+ Mepolizumab (Nucala) Targets and blocks interleukin-5 (IL-5) play a key role in the activation and priming of eosinophils, a type of white blood cell that causes inflammation in asthma. Eosinophilic Asthma: 6+ CRSwNP: 18+ Eosinophilic Granulomatosis with Polyangiitis (EGPA): 18+ Hypereosinophilic Syndrome: ≥6 months Reslizumab (Cinqair) Targets and blocks interleukin-5 (IL-5). Eosinophilic asthma: 18+ Benralizumab (Fasenra) Binds to the IL-5 receptor, preventing eosinophils from growing and causing inflammation. Eosinophilic asthma: 6+ Eosinophilic Granulomatosis with Polyangiitis (EGPA): 18+ Dupilumab (Dupixent) Targets and blocks IL-4 and IL-13 to reduce inflammation Asthma: 6+ Atopic Dermatitis: 6 months+ CRSwNP: 18+ Eosinophilic Esophagitis (EoE): 1+ (> 33 lbs) Approved for prurigo nodularis (PN): 18+ Tezepelumab (Tezspire) Blocks thymic stromal lymphopoietin (TSLP). Asthma: 12+ Tralokinumab (Adbry, Adtralza) Targets and neutralizes interleukin-13 (IL-13). Atopic dermatitis: 12+ Lebrikizumab (Ebglyss) Targets and neutralizes interleukin-13 (IL-13). Atopic dermatitis: 12+ (> 40 lbs) ________ This podcast is made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today's episode. While they support the show, all opinions are our own, and sponsorship doesn't influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement. Disclaimer: This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this episode of The Art of Being Well, Dr. Will Cole is joined by Dr. Gerry Curatola, a trailblazer in biological dentistry and oral microbiome research. Dr. Gerry shares his personal journey into biological dentistry and explains how this holistic approach differs from conventional dental care. From his views on root canals to alternative therapies, he provides valuable insights into the role of the oral microbiome in overall health. They also explore the dangers of conventional toothpaste ingredients and discuss what to do if you still have silver amalgam fillings. This episode is filled with cutting-edge information on how to protect your oral and overall health. For all links mentioned in this episode, visit www.drwillcole.com/podcast.Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Try AG1 and get a FREE bottle of Vitamin D3K2 AND 5 free AG1 Travel Packs with your first purchase at drinkAG1.com/willcole. That's a $48 value for FREE.Start taking charge of your health today and listen and subscribe to Wellness at the Speed of Light, available wherever you get your podcasts!Head to ZBiotics.com/WILLCOLE and use the code WILLCOLE at checkout for 15% off. Visit siphoxhealth.com/WILLCOLE to get 20% off your first at-home blood test and start your journey toward optimal health.Go to http://novoslabs.com/willcole and add the code “WILLCOLE” at checkout for 10% off of your first month's NOVOS Core subscription.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Start EVERY day the Chuck Norris Way with Morning Kick! Get the JOY discount on Morning Kick HERE ---->www.chuckdefense.com/JoyShow moreIf you know the enemy and know yourself, you need not fear the result of a hundred battles. If you know yourself but not the enemy, for every victory gained you will also suffer a defeat. If you know neither the enemy nor yourself, you will succumb in every battle. ~ Sun Tzu, The Art of WarSometimes its important to slow down and see the forest through the trees. Today we will explore the bigger picture and try to make some sense of the absolute chaos so that we can defeat those who seek to subjugate us.So Im very happy to introduce you all to pretty extraordinary guy who pays attention to this stuff and isnt afraid to toss around ideas about the nature of our enemy. Todd Callender was one of the courageous Americans who stood up, spoke out and raged against lockdowns and then organized an army of citizen freedom warriors to educate people about the dangers of COVID 19 vaccines in 2021.Todd is an attorney and the founder and CEO of CloutHub, a freedom first independent network featuring brave Americans who understand the times we live in. Todd is the host of Vaxxchoice which airs daily on the www.clouthub.com and started in early 2021 when it was apparent that governments around the world were going to coerce large segments of the population into taking experimental gene therapy shots. Their mission is to provide daily updates from reputable sources to educate their followers and the world on the true issues at hand._______________________________Show Resources & Links:Follow VaxxChoice on Twitter: @VaxxCHOICESupport VaxxChoice:https://vaxxchoice.comWatch Dr. Rima Laibow on CloutHubhttps://clouthub.com/v/2c87b169-9b85-4171-b22c-d0552b0501c5Join CloutHub:https://clouthub.com________________________________________Please Support Our Sponsors:Start EVERY day the Chuck Norris Way with Morning Kick! Get the JCSID: 54cd54d1fff04909 Extra special bonus from Field of Greens!!!!Plug in the promo code SHANNON for an additional 15% off your purchase!Go to www.fieldofgreens.com to shop and save! Support the showPlease Support Our Sponsors! Achieve financial independence with Colonial Metals Group!!! Set up a SAFE & Secure IRA or 401k with a company who shares your values and supports this show! Learn about your options HERE ——>https://colonialmetalsgroup.com/joy

This week we all sit mesmerized by Dr. Craig Harper of UT as he explains his twenty-five-year study of fire and how it affects habitat. We've all known the importance of dormant season fires on the landscape but Craig explains the importance of fire at other times of the year and the exact benefits. His long study in conjunction with many other smart minds is now being explained and the results are eye opening. He's even preaching to burn smaller areas and he thoroughly explains why. Want to improve bedding? He has an answer. Want to create fawning cover? Want to create poult bugging areas?  Nesting areas? High protein forbs and forages for a healthier deer herd? You have to listen to this one. We think it may be the most definitive explanation of fire we've heard and how using it over the calendar year can help you to accomplish your goals. You might need a notebook. Listen Learn and Enjoy. Show Notes:More on Dr. Craig Harper: https://naturalresources.tennessee.edu/craig-harper/The Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win a ATN Thor 5 Thermal Giveaway here - https://mossyoakgamekeeper.com/atn-giveaway/ Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com

This bonus episode we are joined by crow hunting expert and world class caller Sandy Brady. Imagine killing 8,000 crows a year and over 400 in one hunt!  Sandy takes it very serious and hunts them hard. He explains his set up style and more importantly explains the black birds vocalizations. He's also a big turkey hunter and teaches us that the way most folks try to get a turkey to shock gobble is actually the crows alarm call and that may be hurting your chances of seeing that gobbler. That got our attention. We are fascinated by his crow hunting prowess and intrigued to learn how to step up our crow calling game for locating turkeys. Listen, Learn and Enjoy.           Show Notes:WildTalker Calls: email - wildtalkergc@gmail.comThe Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win a ATN Thor 5 Thermal Giveaway here - https://mossyoakgamekeeper.com/atn-giveaway/ Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com

On this episode we're joined by Pierce Young, a deer biologist with the MDWFP who specializes in private lands advice. We start off asking a lot of questions about fawns, the birthing process, how they learn to nurse, their scent, how mom moves them and hides them plus more. We learned a lot and we went on to discuss what most folks are doing right and wrong in terms of managing their property. We also learned there's a term called deer management fatigue that's a real thing and affects many clubs and gamekeepers. It's an interesting discussion centered around one of our favorite critters, the remarkable white-tailed deer. Listen, Learn and Enjoy.          Show Notes:MDWFP Private Lands Program: https://www.mdwfp.com/privatelands The Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win a ATN Thor 5 Thermal Giveaway here - https://mossyoakgamekeeper.com/atn-giveaway/ Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com

On this week's bonus episode we walk down memory lane with Rusty McDaniels and Joe White, two guys who have been filming for Mossy Oak for a long time. We ask about what they have seen outfitters do to manage deer and turkeys that we could learn from, how they have seen attitudes about conservation change. We learn about the bonding that occurs in a hunting camp, the work ethic that has to be present and the memorable experiences you can miss if you're not paying attention.  We also hear some great stories that include deer, turkeys, Florida panthers, mountain lions and fighting black bears.  This is a fun one. Listen, learn and Enjoy.          Show Notes:Mossy Oak GO - https://go.mossyoak.com/ The Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win a ATN Thor 5 Thermal Giveaway here - https://mossyoakgamekeeper.com/atn-giveaway/ Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com

This week we learn about predator hunting with thermal equipment. Two excellent Louisiana outfitters who specialize in hunting pigs and coyotes with thermals at night join us to explain just how it's done. It's a fascinating discussion and we all learned that we all want to experience this unique hunt. We know first-hand how devastating pigs can be to a property, but these guys have found a way to keep the pressure on them and help their local farmers AND have FUN!  If you have feral pigs in your area, there may be local farmers that would welcome you to help reduce their numbers.  The trappers are using thermals and suppressors to clean up the pigs they can get in traps. We aren't glorifying pig hunting, but pointing out a way to help put the pressure on these destructive vermin. We also learn what a Rougarou is and how did we miss that? Listen, Learn and Enjoy.          Show Notes:Enter for a chance to win a Thor 5 LRF 3-24X  - https://mossyoakgamekeeper.com/atn-giveaway ATN Website - https://www.atncorp.com/ ATN Facebook - https://www.facebook.com/ATNNightVision ATN Instagram - https://www.instagram.com/atncorp Rougarou Hog Control - https://www.facebook.com/RougarouHogControl Mareno's Outfitter and Guide Service - https://www.facebook.com/MarenosOutfitterThe Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com

In this BONUS episode Dr. Erick Larson, the Miss State University Extension Corn and Grain Crops Specialist joins us to explain growing corn for wildlife. Everyone readily admits a field of standing corn can attract and hold wildlife and teamed up with cool season plantings can create beautiful areas of green/grain. However for many food plotters, growing corn can be a bit intimidating. We ask Erick to help us understand how to take agricultural knowledge and apply it to growing smaller plots of corn specifically for wildlife.  Erick's a mild mannered corn genius who recently bow killed a 200-inch whitetail in Kansas.  It's a great discussion. Listen, Learn and Enjoy.          Show Notes:Dr. Erick Larson, MSU Research Professor - https://www.pss.msstate.edu/associate.php?id=61 Wildlife Sweet Corn - https://www.plantbiologic.com/products/wildlife-sweet-corn-food-plot-seed The Guide's Choice. BioLogic's #1 Waterfowl Planting - Learn More Here Enter for your chance to win your very own LS MT225s Compact Tractor and accessories. Learn more and sign up at: mossyoakgamekeeper.com/giveawaySupport the Show.Stay connected with GameKeepers: Enter the Gamekeeper LS Tractor Giveaway!: https://mossyoakgamekeeper.com/gamekeeper-ls-tractor-giveaway/ Instagram: @mossyoakgamekeepers Facebook: @GameKeepers Twitter: @MOGameKeepers YouTube: @MossyOakGameKeepers Website: https://mossyoakgamekeeper.com/ Subscribe to Gamekeepers Magazine: https://bit.ly/GK_Magazine Buy a Single Issue of Gamekeepers Magazine: https://bit.ly/GK_Single_Issue Join our Newsletters: Field Notes - https://bit.ly/GKField_Notes | The Branch - https://bit.ly/the_branch Have a question for us or a podcast idea? Email us at gamekeepers@mossyoak.com